טוען...
CD59 Blockade Enhances Antigen Specific CD4(+) T Cell Responses In Humans: A New Target For Cancer Immunotherapy?
CD59, a broadly expressed GPI anchored molecule, regulates formation of the membrane attack complex of the complement cascade. We previously demonstrated that mouse CD59 also down-modulates CD4(+) T cell activity in vivo. In this study, we explored the role of CD59 on human CD4(+) T cells. Our data...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2704398/ https://ncbi.nlm.nih.gov/pubmed/19380765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.0804243 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|